(Q38061056)

28 August 2017

1 reference

title

Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms (English)

1 reference

28 August 2017

Vincent Emery

9

0 references

Alan Jardine

object named as

Alan G Jardine

4

0 references

author name string

Daniel C Brennan

1

1 reference

28 August 2017

José M Aguado

2

1 reference

28 August 2017

Luciano Potena

3

1 reference

28 August 2017

Christophe Legendre

5

1 reference

28 August 2017

Marcus D Säemann

6

1 reference

28 August 2017

Nicolas J Mueller

7

1 reference

28 August 2017

Pierre Merville

8

1 reference

28 August 2017

Björn Nashan

10

1 reference

28 August 2017

publication date

20 November 2012

1 reference

Reviews in Medical Virology

28 August 2017

published in

1 reference

28 August 2017

volume

23

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

97-125

1 reference

28 August 2017

1 reference

Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.

21 January 2018

1 reference

An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States

21 January 2018

1 reference

A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature

21 January 2018

1 reference

Infection in organ-transplant recipients

21 January 2018

1 reference

Infection in solid-organ transplant recipients

21 January 2018

1 reference

The association between hepatitis C infection and survival after orthotopic liver transplantation

21 January 2018

1 reference

Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems

21 January 2018

1 reference

Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients

21 January 2018

1 reference

HCV recurrence in HIV-infected patients after liver transplant

21 January 2018

1 reference

The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers

21 January 2018

1 reference

Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.

21 January 2018

1 reference

Cytomegalovirus infection and new-onset post-transplant diabetes mellitus

21 January 2018

1 reference

Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy

21 January 2018

1 reference

Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.

21 January 2018

1 reference

Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States

21 January 2018

1 reference

Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients

21 January 2018

1 reference

The pleiotropic effects of Kaposi's sarcoma herpesvirus

21 January 2018

1 reference

Global epidemiology of hepatitis C virus infection

21 January 2018

1 reference

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

21 January 2018

1 reference

Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system

21 January 2018

1 reference

Parvovirus 4 in French in-patients: a study of hemodialysis and lung transplant cohorts.

21 January 2018

1 reference

Skin infections in organ transplant recipients

21 January 2018

1 reference

The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients.

21 January 2018

1 reference

The changing role of mTOR kinase in the maintenance of protein synthesis during human cytomegalovirus infection

21 January 2018

1 reference

CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages.

21 January 2018

1 reference

Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection

21 January 2018

1 reference

Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients

21 January 2018

1 reference

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials

21 January 2018

1 reference

Predictive factors of outcome in patients transplanted for hepatitis B.

21 January 2018

1 reference

The addition of mycophenolate mofetil for suppressing hepatitis B virus replication in liver recipients who developed lamivudine resistance--no beneficial effect

21 January 2018

1 reference

Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients

21 January 2018

1 reference

Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma

21 January 2018

1 reference

Conversion to sirolimus: a useful strategy for recalcitrant cutaneous viral warts in liver transplant recipient.

21 January 2018

1 reference

Parvovirus B19 infection after transplantation: a review of 98 cases

21 January 2018

1 reference

Plasmacytoid dendritic cell reconstitution following bone marrow transplantation: subnormal recovery and functional deficit of IFN-alpha/beta production in response to herpes simplex virus

21 January 2018

1 reference

Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro

21 January 2018

1 reference

Regulation of Hepatitis B Virus Replication by the Phosphatidylinositol 3-Kinase-Akt Signal Transduction Pathway

21 January 2018

1 reference

Cellular growth inhibition by FK778 is linked to G1 arrest or S phase accumulation, dependent on the functional status of the retinoblastoma protein

21 January 2018

1 reference

Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide

21 January 2018

1 reference

Effects of cyclosporine and hydrocortisone on Kaposi's sarcoma-associated herpesvirus genome replication and cell apoptosis induction

21 January 2018

1 reference

The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia

21 January 2018

1 reference

The anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil.

21 January 2018

1 reference

Rapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug

21 January 2018

1 reference

Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein

21 January 2018

1 reference

Modalities to decrease stromal herpes simplex keratitis reactivation rates

21 January 2018

1 reference

Immunosuppressive dose of azathioprine inhibits replication of human cytomegalovirus in vitro

21 January 2018

1 reference

The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis

21 January 2018

1 reference

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

21 January 2018

1 reference

CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes

21 January 2018

1 reference

Leukopenia due to parvovirus B19 in a Crohn's disease patient using azathioprine.

21 January 2018

1 reference

Parvovirus-B19-associated complications in renal transplant recipients

21 January 2018

1 reference

FK506 in liver transplantation for chronic hepatitis B: in vitro studies on lymphocyte activation and virus replication

21 January 2018

1 reference

Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment

21 January 2018

1 reference

Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus

21 January 2018

1 reference

Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?

21 January 2018

1 reference

Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University

21 January 2018

1 reference

Epstein-Barr Virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy.

21 January 2018

1 reference

Cyclosporine promotes epstein-barr virus-infected human B-cell transformation assayed by three correlated assay methods

21 January 2018

1 reference

Cyclosporin A-induced lipid and protein oxidation in human B-cells and in Epstein-Barr virus-infected B-cells is prevented by antioxidants

21 January 2018

1 reference

Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease

21 January 2018

1 reference

Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes

21 January 2018

1 reference

Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients

21 January 2018

1 reference

Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry.

21 January 2018

1 reference

Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil

21 January 2018

1 reference

Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression

21 January 2018

1 reference

The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders

21 January 2018

1 reference

Successful management of recurrent Epstein-Barr virus-associated multilocular leiomyosarcoma after cardiac transplantation

21 January 2018

1 reference

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

21 January 2018

1 reference

Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines.

21 January 2018

1 reference

The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience

21 January 2018

1 reference

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

Effect of FK-506 on replication of human cytomegalovirus in vitro

21 January 2018

1 reference

Concurrent antiviral and immunosuppressive activities of leflunomide in vivo

21 January 2018

1 reference

Cyclosporine inhibits mouse cytomegalovirus infection via a cyclophilin-dependent pathway specifically in neural stem/progenitor cells

21 January 2018

1 reference

Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.

21 January 2018

1 reference

Cytomegalovirus infection as a common complication following liver transplantation.

21 January 2018

1 reference

Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.

21 January 2018

1 reference

Differential effects of prednisolone and azathioprine on the development of human cytomegalovirus replication post liver transplantation

21 January 2018

1 reference

Reduced exposure to calcineurin inhibitors in renal transplantation

21 January 2018

1 reference

Cytomegalovirus infection renal transplant recipients: risk factors and outcome

21 January 2018

1 reference

The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation

21 January 2018

1 reference

Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols

21 January 2018

1 reference

Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras

21 January 2018

1 reference

Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients.

21 January 2018

1 reference

Low incidence of cytomegalovirus disease in liver transplant recipients receiving sirolimus primary immunosuppression with 3-day corticosteroid taper

21 January 2018

1 reference

Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study

21 January 2018

1 reference

Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes

21 January 2018

1 reference

Leflunomide: a possible alternative for gangciclovir sensitive and resistant cytomegalovirus infections

21 January 2018

1 reference

Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.

21 January 2018

1 reference

Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778.

21 January 2018

1 reference

Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats

21 January 2018

1 reference

Leflunomide therapy for cytomegalovirus disease in renal allograft recepients

21 January 2018

1 reference

A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients

21 January 2018

1 reference

Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation.

21 January 2018

1 reference

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection

21 January 2018

1 reference

The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients

21 January 2018

1 reference

Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs

21 January 2018

1 reference

Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation.

21 January 2018

1 reference

The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients

21 January 2018

1 reference

Liver transplantation in the United States, 1999-2008.

21 January 2018

1 reference

Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811.

21 January 2018

1 reference

Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase

21 January 2018

1 reference

Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes

21 January 2018

1 reference

Specific inhibition of hepatitis C virus replication by cyclosporin A.

21 January 2018

1 reference

Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy

21 January 2018

1 reference

Cyclosporine Inhibits a Direct Interaction between Cyclophilins and Hepatitis C NS5A

21 January 2018

1 reference

21 January 2018

Cyclophilin inhibitors

1 reference

Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.

21 January 2018

1 reference

12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus

21 January 2018

1 reference

Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.

21 January 2018

1 reference

Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome

21 January 2018

1 reference

Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.

21 January 2018

1 reference

Cyclosporin a for treatment of hepatitis C virus after liver transplantation

21 January 2018

1 reference

The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C.

21 January 2018

1 reference

Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study.

21 January 2018

1 reference

Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus

21 January 2018

1 reference

Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C.

21 January 2018

1 reference

Effect of antimetabolite immunosuppressants on Flaviviridae, including hepatitis C virus.

21 January 2018

1 reference

Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.

21 January 2018

1 reference

The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.

21 January 2018

1 reference

A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection

21 January 2018

1 reference

Hepatitis C after renal transplantation: histopathological correlations

21 January 2018

1 reference

Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil

21 January 2018

1 reference

Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C.

21 January 2018

1 reference

A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.

21 January 2018

1 reference

MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course

21 January 2018

1 reference

Hepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTOR

21 January 2018

1 reference

Sirolimus has a potential to influent viral recurrence in HCV positive liver transplant candidates

21 January 2018

1 reference

The impact of sirolimus on hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles

21 January 2018

1 reference

Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions

21 January 2018

1 reference

Prospective study of infection and nephropathy due to BK and JC polyomavirus in 76 kidney transplant recipients

21 January 2018

1 reference

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations

21 January 2018

1 reference

In vitro effect of cyclosporin A on primary and chronic BK polyoma virus infection in Vero E6 cells

21 January 2018

1 reference

A suppressive effect of cyclosporine A on replication and noncoding control region activation of polyomavirus BK virus

21 January 2018

1 reference

Risk factors for polyoma virus nephropathy

21 January 2018

1 reference

Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction

21 January 2018

1 reference

Immunosuppression and murine polyomavirus infection

21 January 2018

1 reference

Suppression of early and chronic BK polyoma virus replication by mycophenolic acid in Vero cells

21 January 2018

1 reference

Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients

21 January 2018

1 reference

Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study

21 January 2018

1 reference

Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy

21 January 2018

1 reference

Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population

21 January 2018

1 reference

Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system

21 January 2018

1 reference

Treatment of renal allograft polyoma BK virus infection with leflunomide

21 January 2018

1 reference

Leflunomide inhibition of BK virus replication in renal tubular epithelial cells

21 January 2018

1 reference

Leflunomide for polyomavirus type BK nephropathy

21 January 2018

1 reference

Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection

21 January 2018

1 reference

Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome

21 January 2018

1 reference

Treatment of polyomavirus infection in kidney transplant recipients: a systematic review.

21 January 2018

1 reference

Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients

21 January 2018

1 reference

Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy.

21 January 2018

1 reference

BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy.

21 January 2018

1 reference

Novel activities of cyclophilin A and cyclosporin A during HIV-1 infection of primary lymphocytes and macrophages

21 January 2018

1 reference

Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells

21 January 2018

1 reference

Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1.

21 January 2018

1 reference

Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle

21 January 2018

1 reference

The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells

21 January 2018

1 reference

FK506-binding protein (FKBP) partitions a modified HIV protease inhibitor into blood cells and prolongs its lifetime in vivo

21 January 2018

1 reference

Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation

21 January 2018

1 reference

Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

21 January 2018

1 reference

Anti-HIV-1 activity of leflunomide: a comparison with mycophenolic acid and hydroxyurea

21 January 2018

1 reference

In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.

21 January 2018

1 reference

Inhibition of infectivity of human immunodeficiency virus by a novel nucleoside, oxetanocin, and related compounds

21 January 2018

1 reference

Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the antiviral nucleoside 2' ,3'-dideoxyguanosine

21 January 2018

1 reference

A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection

21 January 2018

1 reference

Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients.

21 January 2018

1 reference

The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication

21 January 2018

1 reference

Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin

21 January 2018

1 reference

Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1.

21 January 2018

1 reference

Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonists

21 January 2018

1 reference

HIV-associated nephropathy: role of mammalian target of rapamycin pathway.

21 January 2018

1 reference

First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation.

21 January 2018

1 reference

Potential use of rapamycin in HIV infection

21 January 2018

1 reference

Inhibition of HIV replication by A77 1726, the active metabolite of leflunomide, in combination with pyrimidine nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

Outcomes of kidney transplantation in HIV-infected recipients

21 January 2018

1 reference

Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine.

21 January 2018

1 reference

Paradoxical aspects of rapamycin immunobiology in transplantation

21 January 2018

1 reference

Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells.

21 January 2018

1 reference

The multifunctional role of mTOR in innate immunity: implications for transplant immunity.

21 January 2018

1 reference

Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro

21 January 2018

1 reference

Implication of gammadelta T cells in the human immune response to cytomegalovirus

21 January 2018

1 reference

Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells

21 January 2018

1 reference

mTOR regulates memory CD8 T-cell differentiation

21 January 2018

1 reference

A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity

21 January 2018

1 reference

Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation

21 January 2018

1 reference

Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.

21 January 2018

1 reference

Role of the hypothalamic-pituitary-adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products

21 January 2018

1 reference

Immunosuppressive drugs for kidney transplantation.

21 January 2018

1 reference

The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis

21 January 2018

1 reference

Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective

21 January 2018

1 reference

Update on immunizations in solid organ transplant recipients: what clinicians need to know

21 January 2018

1 reference

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

21 January 2018

1 reference

Viral Hepatitis in Solid Organ Transplant Recipients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.1733

1 reference

28 August 2017

1 reference